A new study has highlighted the potential of two compounds—tetrahydrocannabivarin (THCV) and cannabidiol (CBD)—in promoting weight loss, shedding light on their promising roles in managing body weight and related metabolic processes.
Recent research in preclinical mouse models has unveiled promising findings about the combined effects of cannabidiol (CBD) and metformin in addressing behavioural challenges.
The global industrial hemp market is on a rapid growth trajectory, with projections indicating a compound annual growth rate (CAGR) of 20.1% over the next several years.
